Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Higher Risk Patients”

3,595 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,595 results

Testing effectiveness (Phase 2)Looking for participantsNCT04061239
What this trial is testing

Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML

Who this might be right for
MDSAML
GWT-TUD GmbH 150
Not applicableStudy completedNCT01187667
What this trial is testing

Evaluation of Delirium Prevention in Critically Ill Patients

Who this might be right for
Delirium
Radboud University Medical Center 650
Not applicableLooking for participantsNCT06509945
What this trial is testing

Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Not applicableActive Not RecruitingNCT04011722
What this trial is testing

Portico Next Generation Approval Study

Who this might be right for
Symptomatic Severe Aortic Stenosis
Abbott Medical Devices 333
Not applicableUnknownNCT05430737
What this trial is testing

A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer

Who this might be right for
Prostate CancerStereotactic Body RadiotherapyHigh-risk+2 more
West China Hospital 60
Not applicableLooking for participantsNCT06274645
What this trial is testing

IVUS CHIP China Registry

Who this might be right for
Complex Higher Risk Indicated Patients Undergoing PCI
Shanghai Zhongshan Hospital 2,020
Not applicableStudy completedNCT03817801
What this trial is testing

Comparison of Scoring Balloon and Conventional Balloon Predilation Before Drug Coated Balloon for de Novo Lesion in Patients With High Bleeding Risk

Who this might be right for
Coronary Artery Disease
Nanjing First Hospital, Nanjing Medical University 60
Testing effectiveness (Phase 2)UnknownNCT01423175
What this trial is testing

ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS

Who this might be right for
Acute Myeloid LeukemiaMDS
Hannover Medical School 60
Not applicableStudy completedNCT04961619
What this trial is testing

Adjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma.

Who this might be right for
Melanoma
Novartis Pharmaceuticals 39
Very early researchEnded earlyNCT02047539
What this trial is testing

Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis

Who this might be right for
Clinical High Risk for Psychosis
Yale University 1
Testing effectiveness (Phase 2)Looking for participantsNCT04996875
What this trial is testing

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Who this might be right for
Advanced Systemic Mastocytosis (AdvSM)SM With an Associated Hematologic Neoplasm (SM-AHN)Mast Cell Leukemia (MCL)+1 more
Cogent Biosciences, Inc. 140
Not applicableUnknownNCT01688232
What this trial is testing

The Immunoscore as a Prognostic Marker for Patients With a Colorectal Cancer

Who this might be right for
Colorectal CancerSurgical Resection of the Colorectal Tumor
Assistance Publique - Hôpitaux de Paris 459
Testing effectiveness (Phase 2)Looking for participantsNCT07050771
What this trial is testing

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

Who this might be right for
Hepatopancreaticobiliary (HPB) MalignancyOvarian Cancer (OvCa)Kidney Cancers+1 more
The Methodist Hospital Research Institute 148
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Post-approval studies (Phase 4)Study completedNCT04817033
What this trial is testing

Sedation Complications in Urology During Spinal Anesthesia With Dexmedetomidine or Midazolam Regarding OSA Risk

Who this might be right for
AnesthesiaAnesthesia ComplicationOsa Syndrome+5 more
University Hospital of Split 115
Testing effectiveness (Phase 2)Looking for participantsNCT02605421
What this trial is testing

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Masonic Cancer Center, University of Minnesota 12
Not applicableStudy completedNCT05797116
What this trial is testing

Practice Variation in Preoperative MDT Meetings

Who this might be right for
Multidisciplinary CommunicationPreoperative CarePatient Care Team
Rijnstate Hospital 54
Not applicableUnknownNCT01383304
What this trial is testing

Aspirin Response in High Risk Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery DiseaseMyocardial InfarctionDiabetes Mellitus+1 more
University of Aarhus 906
Not applicableStudy completedNCT02817581
What this trial is testing

NEWS and Rapid Lactate Testing for Early Identification of High Risk Patients in the Emergency Department

Who this might be right for
Triage Category 3 (Urgent)
Chinese University of Hong Kong 1,255
Not applicableNot Yet RecruitingNCT07015021
What this trial is testing

The Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM Patients

Who this might be right for
Multiple MyelomaCarfilzomibDaratumumab+1 more
The First Affiliated Hospital of Soochow University 72
Load More Results